Modified VP22 localizes to the cell nucleus during synchronized herpes simplex virus type 1 infection
1Department of Microbiology, Mount Sinai School of Medicine, New York, New York 10029, USA.
Insights
Herpes simplex virus protein VP22 localizes to the cytoplasm early in infection and the nucleus late in infection. Modification of VP22, including phosphorylation, occurs as it moves to the nucleus during productive HSV-1 infection.
Area of Science:
- Virology
- Molecular Biology
- Cell Biology
Background:
- The UL49 gene product (VP22) of herpes simplex virus (HSV) is a virion phosphoprotein.
- Previous studies indicated a difference in VP22 electrophoretic mobility between virions and infected-cell nuclei, suggesting undermodification in virions.
Purpose of the Study:
- To characterize the biological and biochemical properties of HSV-1 VP22 throughout productive infection.
- To understand the subcellular localization and modification status of VP22 during HSV-1 infection.
Main Methods:
- Indirect immunofluorescence to determine VP22 subcellular localization.
- Synchronized HSV-1 infection system to track VP22 dynamics.
- Analysis of VP22 electrophoretic mobility in denaturing gels.
- Radiolabeling with [32P]orthophosphate to assess VP22 phosphorylation.
Main Results:
- VP22 exhibits distinct cytoplasmic, diffuse, and nuclear localizations.
- VP22 shifts from predominantly cytoplasmic early in infection to nuclear late in infection.
- VP22 exists as at least three electrophoretic species (VP22a, VP22b, VP22c) with varying mobility.
- Low-mobility VP22 species are abundant early in infection, while high-mobility species accumulate later.
- Cytoplasmic VP22 does not incorporate [32P]orthophosphate, but nuclear VP22 does.
Conclusions:
- VP22 modification, including phosphorylation, coincides with its nuclear accumulation during productive HSV-1 infection.
- The observed changes in VP22 localization and modification state are key aspects of HSV-1 replication.
Abstract:
The UL49 gene product (VP22) of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) is a virion phosphoprotein which accumulates inside infected cells at late stages of infection. We previously (J. A. Blaho, C. Mitchell, and B. Roizman, J. Biol. Chem. 269:17401-17410, 1994) discovered that the form of VP22 packaged into infectious virions differed from VP22 extracted from infected-cell nuclei in that the virion-associated form had a higher electrophoretic mobility in denaturing gels. Based on these results, we proposed that VP22 in virions was "undermodified" in some way. The goal of this study is to document the biological and biochemical properties of VP22 throughout the entire course of a productive HSV-1 infection. We now report the following. (i) VP22 found in infected cells is distributed in at least three distinct subcellular localizations, which we define as cytoplasmic, diffuse, and nuclear, as measured by indirect immunofluorescence. (ii) Using a synchronized infection system, we determined that VP22 exists predominantly in the cytoplasm early in infection and accumulates in the nucleus late in infection. (iii) While cytoplasmic VP22 colocalizes with the HSV-1 glycoprotein D early in infection, the nuclear form of VP22 is not restricted to replication compartments which accumulate ICP4. (iv) VP22 migrates as at least three unique electrophoretic species in denaturing sodium dodecyl sulfate-DATD-polyacrylamide gels. VP22a, VP22b, and VP22c have high, intermediate, and low mobility, respectively. (v) The relative distribution of the various forms of VP22 derived from infected whole-cell extracts varies during the course of infection such that low-mobility species predominate at early times and high-mobility forms accumulate later. (vi) The highest-mobility forms of VP22 partition with the cytoplasmic fraction of infected cells, while the lowest-mobility forms are associated with the nuclear fraction. (vii) Finally, full-length VP22 which partitions in the nucleus incorporates radiolabel from [32P]orthophosphate whereas cytoplasmic VP22 does not. Based on these results, we conclude that modification of VP22 coincides with its appearance in the nucleus during the course of productive HSV-1 infection.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Herpes


